Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Наследственный рак желудка: молекулярно-генетические и клинические аспекты
Наследственный рак желудка: молекулярно-генетические и клинические аспекты
М.П.Никулин, Л.Н.Любченко, В.Ю.Сельчук, И.С.Стилиди. Наследственный рак желудка: молекулярно-генетические и клинические аспекты. Онкология. 2006; 2: 22-27.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Max Parkin D, Freddie Bray, Ferlay J, Paola Pisani. Global Cancer Statistics, 2002; (http://caonline.amcancersoc.org/cgi/content/full/55/2/74).
2. Hai-Dan Wang, Jun Ren, Lian Zhang, CDH1 germline mutation in hereditary gastric carcinoma. World Gastroenterol 2004; 10 (2): 3088–93.
3. Аксель Е.М., Давыдов М.И. Злокачественные новообразования в России и странах СНГ в 2002 году. Под ред. акад. РАН и РАМН, проф. М.И.Давыдова и д-а биол. наук Е.М.Аксель. М., 2004; с. 110.
4. Parsonnet J. When heredity is infectious. Gastroenterology 2000; 118: 222–7.
5. Sokoloff B. Predisposition to cancer in the Bonaparte family. Am J Surg 1938; 40: 673–8.
6. Henry Lynch, William Grady, Gianpaolo Suriano, David Huntsman. Gastric Cancer: New Genetic Developments. J Surgic Oncol (Seminars) 2005; 90: 114–33.
7. Straus EW, Patel H, Chang J et al. H.pylori infection and genotyping in patients undergoing upper endoscopy at inner city hospitals. Dig Dis Sci 2002; 47: 1575–81.
8. Carlos Caldas, Fatima Carneiro, Henry T Lynch et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999; 36: 873–80.
9. Brooks-Wilson AR, Kaurah P, Suriano G et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Gen 2004; 41: 508–17.
10. Suriano G, Vrcelj N, Senz J et al. b-catenin gene amplification: A new mechanism of protein overexpression in cancer. Genes Chromosomes Cancer 2005; 42: 238–46.
11. Zhou YN, Xu CP, Han B et al. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002 Dec; 8 (6): 987–93.
12. Comijn J, Berx G, Vermassen P et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267–78.
13. Blok P, Craanen ME, Dekker W, Tytgat CN. Loss of E-cadherin expression in early gastric cancer. Histopathology 1999; 34: 410–5.
14. Machado JC, Soares P, Carneiro F et al. E-cadherin gene mutation provide a genetic basis for the phenotype divergence of mixed gastric carcinomas. Lab Invest, 1999.
15. Grady WM, Willis J, Guilford PJ et al. Methylation of the CDH1 promoter as the second genetic hit in hereditaty duffuse gastric cancer. Nat Genet 2000; 26: 16–7.
16. Tamura G, Yin J, Wang S et al. E-cadherin gene promoter hypermetilation in primary human gastric carcinomas. J Nat Cancer Inst 2000; 79: 459–65; 92: 569–73.
17. Aarnio M, Salovaara R, Aaltonen LA et al. Features of gastric cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer (Pred Oncol) 1997; 74: 551–5.
18. Park GT, Lee OY, Kwon SJ et al. Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans. J Gastroenterol Hepatol 2003; 18: 1257–63.
19. Cai SJ, Xu Y, Cai GX et al. Clinical characteristics and diagnosis of patitents with hereditary nonpolyposis colorectal cancer. World J Gastroenterol 2003; 9: 284–7.
20. Renkonen-Sinisalo L, Sipponen P, Aarnio M et al. No support for endoscopic surveillance for gastric cancer in hereditary nonpolyposis colorectal cancer. Scand J Gastroenterol 2002; 37: 574–7.
21. Sigano K, Tanaguchi T, Saeki M et al. Germline p53 mutation in a case of Li-Fraumeni syndrome presenting gastric cancer. Jpn J Clin Oncol 1999; 29: 513–6.
22. Hofgartner W, Thorp M, Ramus M et al. Gastric adenocarcinoma associated with fundic gland polyps in a patients with attenuated familial adenomatous polyposis. Am J Gastroenterol 1999; 94: 2275–81.
23. Wallace MH, Philips RKS: Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998; 85: 742–50.
24. Jagelman DG, DeCosse JJ, Busssey HJR. The Leeds Castle Polyposis Group. Upper gastrointestinal cancer in familial polyposis coli. Lancet 1988; i: 1149–51.
25. Amos CI, Keitheri-Cheteri MB, Sabripour M et al. Genotype-phenotype correlation correlation in Peutz-Jeghers syndrome. J Med Genet 2004; 41: 327–33.
26. Giardiello FM, Brensinger JD, Tersmette AC et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119: 1447–53.
27. David G.Huntsmann, Fatima Carneiro, Frank R.Lewis et al. Early Gastric Cancer in young, asymptomatic carriers of germ-line e-cadherin mutations. New Engl J Med 2001; 344 (25): 1903–9.
2. Hai-Dan Wang, Jun Ren, Lian Zhang, CDH1 germline mutation in hereditary gastric carcinoma. World Gastroenterol 2004; 10 (2): 3088–93.
3. Аксель Е.М., Давыдов М.И. Злокачественные новообразования в России и странах СНГ в 2002 году. Под ред. акад. РАН и РАМН, проф. М.И.Давыдова и д-а биол. наук Е.М.Аксель. М., 2004; с. 110.
4. Parsonnet J. When heredity is infectious. Gastroenterology 2000; 118: 222–7.
5. Sokoloff B. Predisposition to cancer in the Bonaparte family. Am J Surg 1938; 40: 673–8.
6. Henry Lynch, William Grady, Gianpaolo Suriano, David Huntsman. Gastric Cancer: New Genetic Developments. J Surgic Oncol (Seminars) 2005; 90: 114–33.
7. Straus EW, Patel H, Chang J et al. H.pylori infection and genotyping in patients undergoing upper endoscopy at inner city hospitals. Dig Dis Sci 2002; 47: 1575–81.
8. Carlos Caldas, Fatima Carneiro, Henry T Lynch et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999; 36: 873–80.
9. Brooks-Wilson AR, Kaurah P, Suriano G et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Gen 2004; 41: 508–17.
10. Suriano G, Vrcelj N, Senz J et al. b-catenin gene amplification: A new mechanism of protein overexpression in cancer. Genes Chromosomes Cancer 2005; 42: 238–46.
11. Zhou YN, Xu CP, Han B et al. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002 Dec; 8 (6): 987–93.
12. Comijn J, Berx G, Vermassen P et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267–78.
13. Blok P, Craanen ME, Dekker W, Tytgat CN. Loss of E-cadherin expression in early gastric cancer. Histopathology 1999; 34: 410–5.
14. Machado JC, Soares P, Carneiro F et al. E-cadherin gene mutation provide a genetic basis for the phenotype divergence of mixed gastric carcinomas. Lab Invest, 1999.
15. Grady WM, Willis J, Guilford PJ et al. Methylation of the CDH1 promoter as the second genetic hit in hereditaty duffuse gastric cancer. Nat Genet 2000; 26: 16–7.
16. Tamura G, Yin J, Wang S et al. E-cadherin gene promoter hypermetilation in primary human gastric carcinomas. J Nat Cancer Inst 2000; 79: 459–65; 92: 569–73.
17. Aarnio M, Salovaara R, Aaltonen LA et al. Features of gastric cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer (Pred Oncol) 1997; 74: 551–5.
18. Park GT, Lee OY, Kwon SJ et al. Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans. J Gastroenterol Hepatol 2003; 18: 1257–63.
19. Cai SJ, Xu Y, Cai GX et al. Clinical characteristics and diagnosis of patitents with hereditary nonpolyposis colorectal cancer. World J Gastroenterol 2003; 9: 284–7.
20. Renkonen-Sinisalo L, Sipponen P, Aarnio M et al. No support for endoscopic surveillance for gastric cancer in hereditary nonpolyposis colorectal cancer. Scand J Gastroenterol 2002; 37: 574–7.
21. Sigano K, Tanaguchi T, Saeki M et al. Germline p53 mutation in a case of Li-Fraumeni syndrome presenting gastric cancer. Jpn J Clin Oncol 1999; 29: 513–6.
22. Hofgartner W, Thorp M, Ramus M et al. Gastric adenocarcinoma associated with fundic gland polyps in a patients with attenuated familial adenomatous polyposis. Am J Gastroenterol 1999; 94: 2275–81.
23. Wallace MH, Philips RKS: Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998; 85: 742–50.
24. Jagelman DG, DeCosse JJ, Busssey HJR. The Leeds Castle Polyposis Group. Upper gastrointestinal cancer in familial polyposis coli. Lancet 1988; i: 1149–51.
25. Amos CI, Keitheri-Cheteri MB, Sabripour M et al. Genotype-phenotype correlation correlation in Peutz-Jeghers syndrome. J Med Genet 2004; 41: 327–33.
26. Giardiello FM, Brensinger JD, Tersmette AC et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119: 1447–53.
27. David G.Huntsmann, Fatima Carneiro, Frank R.Lewis et al. Early Gastric Cancer in young, asymptomatic carriers of germ-line e-cadherin mutations. New Engl J Med 2001; 344 (25): 1903–9.
Авторы
М.П.Никулин, Л.Н.Любченко, В.Ю.Сельчук, И.С.Стилиди
НИИ КО ГУ РОНЦ РАМН им. Н.Н.Блохина, Москва
НИИ КО ГУ РОНЦ РАМН им. Н.Н.Блохина, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.